These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28281418)

  • 1. Carpe diem ('Seize the day'): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa.
    Loveday M; Cox H
    S Afr Med J; 2017 Feb; 107(3):176-177. PubMed ID: 28281418
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa.
    Davies GR; Pillay M; Sturm AW; Wilkinson D
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):799-804. PubMed ID: 10488888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistant tuberculosis: trends and control.
    Prasad R; Gupta N; Singh M
    Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis around the world: what progress has been made?
    Falzon D; Mirzayev F; Wares F; Baena IG; Zignol M; Linh N; Weyer K; Jaramillo E; Floyd K; Raviglione M
    Eur Respir J; 2015 Jan; 45(1):150-60. PubMed ID: 25261327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XDR-TB or not XDR-TB? That is the question.
    Bateman C
    S Afr Med J; 2007 May; 97(5):318, 320, 322. PubMed ID: 17599208
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
    Garrido Mda S; Bührer-Sékula S; Souza AB; de Oliveira GP; Antunes IA; Mendes JM; Saraceni V; Martinez-Espinosa FE; Ramasawmy R
    Int J Tuberc Lung Dis; 2015 May; 19(5):531-6. PubMed ID: 25868020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multidrug resistance tuberculosis - current problems].
    Kruczak K; Nizankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2009; 77(3):276-83. PubMed ID: 19591099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.
    Ebonwu JI; Tint KS; Ihekweazu C
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1043-8. PubMed ID: 23827028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB?
    Edginton ME; Miller DL; Burney P; El Sony AI; Lwilla FI; O'Brien R; Roldan MB; Roldan A; Srinath S
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1094-6. PubMed ID: 20819252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-resistant and extensively drug-resistant tuberculosis in southern Africa.
    Grobusch MP
    Curr Opin Pulm Med; 2010 May; 16(3):180-5. PubMed ID: 20154624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 16. Representations of MDR and XDR-TB in South African newspapers.
    Daku M; Gibbs A; Heymann J
    Soc Sci Med; 2012 Jul; 75(2):410-8. PubMed ID: 22534376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa.
    Schnippel K; Rosen S; Shearer K; Martinson N; Long L; Sanne I; Variava E
    Trop Med Int Health; 2013 Jan; 18(1):109-16. PubMed ID: 23170876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
    Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
    Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.